Literature DB >> 24373166

OPTN/SRTR 2012 Annual Data Report: kidney.

A J Matas1, J M Smith, M A Skeans, B Thompson, S K Gustafson, M A Schnitzler, D E Stewart, W S Cherikh, J L Wainright, J J Snyder, A K Israni, B L Kasiske.   

Abstract

For most end-stage renal disease patients, successful kidney transplant provides substantially longer survival and better quality of life than dialysis, and preemptive transplant is associated with better outcomes than transplants occurring after dialysis initiation. However, kidney transplant numbers in the us have not changed for a decade. Since 2004, the total number of candidates on the waiting list has increased annually. Median time to transplant for wait-listed adult patients increased from 2.7 years in 1998 to 4.2 years in 2008. The discard rate of deceased donor kidneys has also increased, and the annual number of living donor transplants has decreased. The number of pediatric transplants peaked at 899 in 2005, and has remained steady at approximately 750 over the past 3 years; 40.9% of pediatric candidates undergo transplant within 1 year of wait-listing. Graft survival continues to improve for both adult and pediatric recipients. Kidney transplant is one of the most cost-effective surgical interventions; however, average reimbursement for recipients with primary Medicare coverage from transplant through 1 year posttransplant was comparable to the 1-year cost of care for a dialysis patient. Rates of rehospitalization are high in the first year posttransplant; annual costs after the first year are lower. © Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  End-stage renal disease; kidney transplant; organ allocation; waiting list

Mesh:

Year:  2014        PMID: 24373166     DOI: 10.1111/ajt.12579

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  113 in total

1.  Donor-Specific HLA Antibody IgG Subclasses Are Associated with Phenotypes of Antibody-Mediated Rejection in Sensitized Renal Allograft Recipients.

Authors:  Stanley C Jordan
Journal:  J Am Soc Nephrol       Date:  2015-08-20       Impact factor: 10.121

Review 2.  Role for urinary biomarkers in diagnosis of acute rejection in the transplanted kidney.

Authors:  Basma Merhi; George Bayliss; Reginald Y Gohh
Journal:  World J Transplant       Date:  2015-12-24

3.  The Kidney Donor Profile Index (KDPI) of marginal donors allocated by standardized pretransplant donor biopsy assessment: distribution and association with graft outcomes.

Authors:  I Gandolfini; C Buzio; P Zanelli; A Palmisano; E Cremaschi; A Vaglio; G Piotti; L Melfa; G La Manna; G Feliciangeli; M Cappuccilli; M P Scolari; I Capelli; L Panicali; O Baraldi; S Stefoni; A Buscaroli; L Ridolfi; A D'Errico; G Cappelli; D Bonucchi; E Rubbiani; A Albertazzi; A Mehrotra; P Cravedi; U Maggiore
Journal:  Am J Transplant       Date:  2014-08-25       Impact factor: 8.086

4.  Factors leading to the discard of deceased donor kidneys in the United States.

Authors:  Sumit Mohan; Mariana C Chiles; Rachel E Patzer; Stephen O Pastan; S Ali Husain; Dustin J Carpenter; Geoffrey K Dube; R John Crew; Lloyd E Ratner; David J Cohen
Journal:  Kidney Int       Date:  2018-05-05       Impact factor: 10.612

5.  The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation.

Authors:  Elisabet Størset; Kristine Hole; Karsten Midtvedt; Stein Bergan; Espen Molden; Anders Åsberg
Journal:  Br J Clin Pharmacol       Date:  2017-02-27       Impact factor: 4.335

6.  Anti-CD47 monoclonal antibody therapy reduces ischemia-reperfusion injury of renal allografts in a porcine model of donation after cardiac death.

Authors:  Min Xu; Xuanchuan Wang; Babak Banan; Danielle L Chirumbole; Sandra Garcia-Aroz; Aparna Balakrishnan; Deepak K Nayak; Zhengyan Zhang; Jianluo Jia; Gundumi A Upadhya; Joseph P Gaut; Ronald Hiebsch; Pamela T Manning; Ningying Wu; Yiing Lin; William C Chapman
Journal:  Am J Transplant       Date:  2017-12-02       Impact factor: 8.086

7.  Approach to the Highly Sensitized Kidney Transplant Candidate.

Authors:  Douglas S Keith; Gayle M Vranic
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-25       Impact factor: 8.237

8.  Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients.

Authors:  David J Taber; Mulugeta Gebregziabher; Elizabeth H Payne; Titte Srinivas; Prabhakar K Baliga; Leonard E Egede
Journal:  Transplantation       Date:  2017-02       Impact factor: 4.939

9.  The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients.

Authors:  Jiang-Tao Tang; Brenda C de Winter; Dennis A Hesselink; Ferdi Sombogaard; Lan-Lan Wang; Teun van Gelder
Journal:  Br J Clin Pharmacol       Date:  2016-11-30       Impact factor: 4.335

Review 10.  Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts.

Authors:  William M Baldwin; Anna Valujskikh; Robert L Fairchild
Journal:  Curr Opin Organ Transplant       Date:  2016-02       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.